MAM
MEC India is Radikal Rice’s Digital AoR
MUMBAI: MEC India, a media and planning agency and a founding partner of Group M, has bagged the digital mandate for Radikal Rice following a multi-agency pitch.
This win comes close on the heels of MEC winning the Britannia business in Bangalore.
Radikal Rice has recently appointed Madison Media as their Media AoR. The media budget of the brand is estimated to be around Rs 250 million.
MEC Interaction Head Ritesh Singh said, “We are delighted to be appointed the digital AoR for Radikal Rice and have some exciting things planned for the brand.”
The agency has already started working on the account. The brand has its presence on social media platforms like Facebook and Twitter. However, the agency is planning a big digital campaign roll out soon. MEC is also redesigning the official website of the brand.
The brand is expected to spend 7-10 per cent of its media budget on its digital campaigns.
Radikal MD Siddharth Chaudhary said, “Keeping in view with the way the digital wave is embracing all walks of life for our consumers, we needed to lay emphasis on engagement and activation. That is the reason we have a full-fledged Digital AOR arrangement with MEC Interaction. What appealed to us about them was the innovative and inventive approach to reaching out to digital audiences across different platforms.”
McCann Erickson is the creative AoR on the account.
Radikal is manufacturer and supplier of premium basmati rice with nutritive value.
Also read:
Madison Media is Radikal Rice’s media AoR
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
